Freedman LS - Search Results

1

A unified method for monitoring and analysing controlled trials.

Grossman J, Parmar MK, Spiegelhalter DJ, Freedman LS. Grossman J, et al. Among authors: freedman ls. Stat Med. 1994 Sep 30;13(18):1815-26. doi: 10.1002/sim.4780131804. Stat Med. 1994. PMID: 7997715

2

Application of Bayesian statistics to decision making during a clinical trial.

Freedman LS, Spiegelhalter DJ. Freedman LS, et al. Stat Med. 1992 Jan 15;11(1):23-35. doi: 10.1002/sim.4780110105. Stat Med. 1992. PMID: 1557573 Clinical Trial.

3

Using replicate observations in observer agreement studies with binary assessments.

Baker SG, Freedman LS, Parmar MK. Baker SG, et al. Among authors: freedman ls. Biometrics. 1991 Dec;47(4):1327-38. Biometrics. 1991. PMID: 1786322

4

Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party).

Parmar MK, Freedman LS, Hargreave TB, Tolley DA. Parmar MK, et al. Among authors: freedman ls. J Urol. 1989 Aug;142(2 Pt 1):284-8. doi: 10.1016/s0022-5347(17)38731-1. J Urol. 1989. PMID: 2501516 Clinical Trial.

5

Comparison of Bayesian with group sequential methods for monitoring clinical trials.

Freedman LS, Spiegelhalter DJ. Freedman LS, et al. Control Clin Trials. 1989 Dec;10(4):357-67. doi: 10.1016/0197-2456(89)90001-9. Control Clin Trials. 1989. PMID: 2691203

6

Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party).

Tolley DA, Hargreave TB, Smith PH, Williams JL, Grigor KM, Parmar MK, Freedman LS, Uscinska BM. Tolley DA, et al. Among authors: freedman ls. Br Med J (Clin Res Ed). 1988 Jun 25;296(6639):1759-61. doi: 10.1136/bmj.296.6639.1759. Br Med J (Clin Res Ed). 1988. PMID: 3136828 Free PMC article. Clinical Trial.

7

A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinion.

Spiegelhalter DJ, Freedman LS. Spiegelhalter DJ, et al. Among authors: freedman ls. Recent Results Cancer Res. 1988;111:195-206. doi: 10.1007/978-3-642-83419-6_24. Recent Results Cancer Res. 1988. PMID: 3140325 No abstract available.

8

Monitoring clinical trials: conditional or predictive power?

Spiegelhalter DJ, Freedman LS, Blackburn PR. Spiegelhalter DJ, et al. Among authors: freedman ls. Control Clin Trials. 1986 Mar;7(1):8-17. doi: 10.1016/0197-2456(86)90003-6. Control Clin Trials. 1986. PMID: 3956212

9

A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinion.

Spiegelhalter DJ, Freedman LS. Spiegelhalter DJ, et al. Among authors: freedman ls. Stat Med. 1986 Jan-Feb;5(1):1-13. doi: 10.1002/sim.4780050103. Stat Med. 1986. PMID: 3961311

10

Stopping rules for clinical trials.

Freedman LS, Lowe D, Macaskill P. Freedman LS, et al. Stat Med. 1983 Apr-Jun;2(2):167-74. doi: 10.1002/sim.4780020210. Stat Med. 1983. PMID: 6648131

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

325 results

Search Page

Filters